305 related articles for article (PubMed ID: 32859541)
41. [Cytogenetic feature of acute biphenotypic leukemia].
Shen YM; Li JY; Xue YQ; Gu QL
Ai Zheng; 2002 May; 21(5):544-6. PubMed ID: 12452051
[TBL] [Abstract][Full Text] [Related]
42. Infantile mixed phenotype acute leukemia (bilineal and biphenotypic) with t(10;11)(p12;q23);MLL-MLLT10.
Lou Z; Zhang CC; Tirado CA; Slone T; Zheng J; Zaremba CM; Oliver D; Chen W
Leuk Res; 2010 Aug; 34(8):1107-9. PubMed ID: 20299091
[TBL] [Abstract][Full Text] [Related]
43. The spectrum of adult B-lymphoid leukemias with BCR-ABL: molecular diagnostic, cytogenetic, and clinical laboratory perspectives.
Klco JM; Kreisel FH; Zehnbauer BA; Kulkarni S; Hassan A; Frater JL
Am J Hematol; 2008 Dec; 83(12):901-7. PubMed ID: 18932238
[TBL] [Abstract][Full Text] [Related]
44. Chronic myeloid leukemia blast crisis presented with AML of t(9;22) and t(3;14) mimicking acute lymphocytic leukemia.
Liu K; Hu J; Wang X; Li L
J Clin Lab Anal; 2019 Oct; 33(8):e22961. PubMed ID: 31218758
[TBL] [Abstract][Full Text] [Related]
45. Mixed-phenotype acute leukemia: clinical and laboratory features and outcome in 100 patients defined according to the WHO 2008 classification.
Matutes E; Pickl WF; Van't Veer M; Morilla R; Swansbury J; Strobl H; Attarbaschi A; Hopfinger G; Ashley S; Bene MC; Porwit A; Orfao A; Lemez P; Schabath R; Ludwig WD
Blood; 2011 Mar; 117(11):3163-71. PubMed ID: 21228332
[TBL] [Abstract][Full Text] [Related]
46. Mixed Phenotype Acute Leukemia: Current Approaches to Diagnosis and Treatment.
Alexander TB; Orgel E
Curr Oncol Rep; 2021 Feb; 23(2):22. PubMed ID: 33544265
[TBL] [Abstract][Full Text] [Related]
47. Clinico-hematological and immunophenotypic profile of acute leukemia of ambiguous lineage: A four year experience from a single tertiary care centre of West India.
Rai V; Brahmbhatt B; Saha A; Thayakaran IP
Indian J Pathol Microbiol; 2024; 67(1):121-127. PubMed ID: 38358200
[TBL] [Abstract][Full Text] [Related]
48. Acute leukemias harboring KMT2A/MLLT10 fusion: a 10-year experience from a single genomics laboratory.
Peterson JF; Sukov WR; Pitel BA; Smoley SA; Pearce KE; Meyer RG; Williamson CM; Smadbeck JB; Vasmatzis G; Hoppman NL; Greipp PT; Baughn LB; Ketterling RP
Genes Chromosomes Cancer; 2019 Aug; 58(8):567-577. PubMed ID: 30707474
[TBL] [Abstract][Full Text] [Related]
49. Clinicoepidemiologic Profile and Outcome Predicted by Minimal Residual Disease in Children With Mixed-phenotype Acute Leukemia Treated on a Modified MCP-841 Protocol at a Tertiary Cancer Institute in India.
Myint HH; Tandon S; Narula G; Prasad M; Subramanian P; Patkar N; Tembhare P; Gujral S; Banavali S
J Pediatr Hematol Oncol; 2020 Oct; 42(7):415-419. PubMed ID: 32976349
[TBL] [Abstract][Full Text] [Related]
50. Clinical cytogenetics in pediatric acute leukemia: an update.
Braoudaki M; Tzortzatou-Stathopoulou F
Clin Lymphoma Myeloma Leuk; 2012 Aug; 12(4):230-7. PubMed ID: 22609262
[TBL] [Abstract][Full Text] [Related]
51. The incidence peaks of the childhood acute leukemias reflect specific cytogenetic aberrations.
Forestier E; Schmiegelow K;
J Pediatr Hematol Oncol; 2006 Aug; 28(8):486-95. PubMed ID: 16912588
[TBL] [Abstract][Full Text] [Related]
52. Acute leukemias with complex karyotype show a similarly poor outcome independent of mixed, myeloid or lymphoblastic immunophenotype: A study from the Bone Marrow Pathology Group.
Kirtek T; Chen W; Laczko D; Bagg A; Koduru P; Foucar K; Venable E; Nichols M; Rogers HJ; Tam W; Orazi A; Hsi ED; Hasserjian RP; Wang SA; Arber DA; Weinberg OK
Leuk Res; 2023 Jul; 130():107309. PubMed ID: 37210875
[TBL] [Abstract][Full Text] [Related]
53. [Detection of fusion gene--integral part of the assessment of children with acute leukemia].
Miron I; Ivanov A; Ivanov I; Dumitraş S
Rev Med Chir Soc Med Nat Iasi; 2011; 115(3):731-5. PubMed ID: 22046779
[TBL] [Abstract][Full Text] [Related]
54. Increasing aclarubicin dose in low-dose cytarabine and aclarubicin in combination with granulocyte colony-stimulating factor (CAG regimen) is efficacious as salvage chemotherapy for relapsed/refractory mixed-phenotype acute leukemia.
Liu L; Qu Q; Jiao W; Zhang Y; Li X; Ding C; Wu D
Leuk Res; 2015 Aug; 39(8):805-11. PubMed ID: 26021434
[TBL] [Abstract][Full Text] [Related]
55. Immunophenotypic challenges in diagnosis of CD79a negativity in a patient with B acute lymphoblastic leukemia harboring intrachromosomal amplification of chromosome 21: a case report.
Berhili A; Bensalah M; ElMalki J; Elyagoubi A; Seddik R
J Med Case Rep; 2021 Oct; 15(1):531. PubMed ID: 34706776
[TBL] [Abstract][Full Text] [Related]
56. Acute leukemia with t(10;11)(p11-p15;q13-q23).
Secco C; Wiernik PH; Bennett JM; Paietta E
Cancer Genet Cytogenet; 1996 Jan; 86(1):31-4. PubMed ID: 8616782
[TBL] [Abstract][Full Text] [Related]
57. Outcomes in patients with mixed phenotype acute leukemia in Morocco.
Bachir F; Zerrouk J; Howard SC; Graoui O; Lahjouji A; Hessissen L; Bennani S; Quessar A; El Aouad R
J Pediatr Hematol Oncol; 2014 Aug; 36(6):e392-7. PubMed ID: 23619119
[TBL] [Abstract][Full Text] [Related]
58. Genomic characterization of chromosome translocations in patients with T/myeloid mixed-phenotype acute leukemia.
Pallavajjala A; Kim D; Li T; Ghiaur G; Jones RJ; Burns KH; Salzberg SL; Ning Y
Leuk Lymphoma; 2018 May; 59(5):1231-1238. PubMed ID: 28882084
[TBL] [Abstract][Full Text] [Related]
59. [Clinical and molecular biologic characteristics of 36 cases of leukemia with 11q23/mll].
Zhao J; Yin YM; Zhao YL; Sun Y; Wang JB; Zhong J; Zhang X; Fei XH; Shan FX; Liu HX; Wang T; Wang H; Tong CR; Wu T; Lu DP
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2010 Dec; 18(6):1381-5. PubMed ID: 21176334
[TBL] [Abstract][Full Text] [Related]
60. [A study of mixed phenotype acute leukemia based on the 2008 World Health Organization classification].
Park J; Chae H; Kim M; Lim J; Kim Y; Lee J; Chung NG; Cho B; Kim HK; Lee S; Han K
Korean J Lab Med; 2010 Dec; 30(6):525-32. PubMed ID: 21157134
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
